Ark INNOVATION UCITS ETF (SWX:ARKK)
Switzerland · Delayed Price · Currency is CHF 7.12
+0.06 (0.92%)
At close: Jun 19, 2026
29.50% (1Y)
| Assets | 240.70M |
| Expense Ratio | 0.78% |
| PE Ratio | 53.17 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +29.50% |
| Volume | 2,348 |
| Open | 7.12 |
| Previous Close | 7.05 |
| Day's Range | 7.12 - 7.12 |
| 52-Week Low | 5.45 |
| 52-Week High | 7.69 |
| Beta | n/a |
| Holdings | 45 |
| Inception Date | Apr 12, 2024 |
About ARKK
ARXK.DE was created on 2024-04-12 by ARK. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 249.89m in AUM and 45 holdings. This product is actively managed and invests primarily in global equity securities of companies involved in disruptive innovation, defined as the introduction of a technologically enabled new product or service that potentially changes the way the world works.
Asset Class Equity
Category Theme
Stock Exchange SIX Swiss Exchange
Ticker Symbol ARKK
Provider ARK
Performance
ARKK had a total return of 29.50% in the past year, including dividends. Since the fund's inception, the average annual return has been 41.58%.
Top 10 Holdings
49.37% of assets| Name | Symbol | Weight |
|---|---|---|
| Tesla, Inc. | TSLA | 8.27% |
| Robinhood Markets, Inc. | HOOD | 6.71% |
| Advanced Micro Devices, Inc. | AMD | 5.47% |
| CRISPR Therapeutics AG | CRSP | 5.25% |
| Space Exploration Technologies Corp. | SPCX | 4.71% |
| Tempus AI, Inc. | TEM | 4.16% |
| Beam Therapeutics Inc. | BEAM | 3.94% |
| Roku, Inc. | ROKU | 3.73% |
| Coinbase Global, Inc. | COIN | 3.57% |
| Twist Bioscience Corporation | TWST | 3.56% |